Stem Cell Approaches in Neurology and Psychiatry
Published October 15, 2008
An industry insider report on innovative research and development in stem cell technology for the central nervous system
- Analyzes the scientific approaches and challenges to utilizing stem cells in the CNS
- Discusses trends and drivers including funding and regulatory issues
- Reveals promising treatment indications and pipelines
- Details cell therapies for Parkinson's, SCI, stroke, Alzheimer's, ALS, MS, retina and more
- Examines business models leveraging the promise of stem cells
- Sheds light on investment opportunities and risks
- Provides in-depth profiles of trendsetters and trailblazers
Table of Contents
Over 125 Companies Included
|
27 Trendsetters for 2009:
- Aastrom Biosciences
- Advanced Cell Technology
- ArunA Biomedical
- Athersys
- Beike Biotechnology Company
- BrainCells, Inc.
- BrainStorm Cell Therapeutics
- California Stem Cell
- Cell Cure Neurosciences
- CellMed AG
- Geron Corporation
- International Stem Cell Corporation
- NeuralStem
- NeuroGeneration
- NeuroNascent
- NeuroNova AB
- Neuronyx
- NsGene A/S
- Pfizer Regenerative Medicine
- Q Therapeutics
- ReNeuron Group
- RhinoCyte
- Stem Cell Sciences
- Stem Cell Therapeutics
- StemCell Technologies
- StemCells, Inc.
- Theradigm, Inc.
|
|
|
